Skip to main content
Take the Quiz

Programming Matters.

As you think about your DBS options, it is important to consider the programming of the device. The programming of the device – how your therapy is set-up, delivered, and maintained over time – ensures you are receiving therapy that meets your needs.

Your brain. Your DBS therapy. Personalized just for you.

Typically, DBS programming is perfected over time. Getting to a point in the therapy that balances symptoms and side-effects can take quite some time and is achieved over many programming sessions.

​We have accepted the challenge to improve this process. Our solution: Image Guided Programming (IGP). IGP provides your physician the ability to see exactly where your leads are located and exactly where your stimulation needs to be delivered.

How Does Image Guided Programming (IGP) Work?

We hear often – How do you know the leads are in the right place?
Or if my condition changes, can my therapy change too?
Image Guided Programming (IGP) answers both questions.

Here is how it works: ​

Images are collected during your DBS procedure​.

Collected images are evaluated to see the exact location of your leads.

The images are loaded into the programming software and therapy is programmed precisely – based on the location of your leads. ​

Stimulation can be adjusted to minimize side affects, at the initial programming and in the future. ​

Giving you your time back

​When your device is programmed with IGP you may spend less time in your programming sessions.* A recent study of 10 patients showed an initial programming time of 20 minutes; this is less than half the time typically spent in a session. The study concluded that Image-Guided Programming drastically reduces programming time without compromising symptom control and patient satisfaction.1

See what doctors are saying​

Hear from physicians who have seen the benefits of Image Guided Programming. ​

Dr. Aristide Merola, a neurologist at The Ohio State University, describes how IGP has transformed the programming experience. 

Dr. Britt Stone, a neurologist at Vanderbilt, explains the evolution of programming and its impact she’s seen on patients.

Learn from Home​

Join us at our next Webinar where you can hear from physicians and patients about their experience programming our device. Get your questions answered, all from the comfort of your home. ​

Register for a webinar

Connect to a DBS Ambassador today

Hear first-hand what it's like to go through the DBS journey.

Connect Now

*Results from case studies are not necessarily predictive of results in other case studies. Results in other studies may vary.

References:

1. Lange F, Steigerwald F, Malzacher T, Brandt GA, Odorfer TM, Roothans J, Reich MM, Fricke P, Volkmann J, Matthies C and Capetian PD (2021) Reduced Programming Time and Strong Symptom Control Even in Chronic Course Through Imaging-Based DBS Programming. Front. Neurol. 12:785529. doi: 10.3389/fneur.2021.785529

Indication for Use: The Boston Scientific Vercise™ PC, Vercise Gevia™, Vercise Genus™ Deep Brain Stimulation Systems are indicated for use in:
-Bilateral stimulation of the subthalamic nucleus (STN) as an adjunctive therapy in reducing some of the symptoms of moderate to advanced levodopa-responsive Parkinson’s disease (PD) that are not adequately controlled with medication.
-Bilateral stimulation of the internal globus pallidus (GPi) as an adjunctive therapy in reducing some of the symptoms of advanced levodopa-responsive Parkinson’s disease (PD) that are not adequately controlled with medication.
-Unilateral thalamic stimulation of the ventral intermediate nucleus (VIM) is indicated for the suppression of tremor in the upper extremity. The system is intended for use in patients who are diagnosed with essential tremor or parkinsonian tremor not adequately controlled by medications and where the tremor constitutes a significant functional disability. 
-Bilateral stimulation of the ventral intermediate nucleus (VIM) of the thalamus for the suppression of disabling upper extremity tremor in adult essential tremor patients whose tremor is not adequately controlled by medications and where the tremor constitutes a significant functional disability.

The Boston Scientific Vercise Deep Brain Stimulation System is indicated for use in:
-Bilateral stimulation of the subthalamic nucleus (STN) as an adjunctive therapy in reducing some of the symptoms of moderate to advanced levodopa-responsive Parkinson’s disease (PD) that are not adequately controlled with medication.

Contraindications: The Boston Scientific Deep Brain Stimulation (DBS) Systems are not recommended for patients who will be exposed to the following procedures: Diathermy as either a treatment for a medical condition or as part of a surgical procedure, Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS).  The safety of these therapies in patients implanted with the Boston Scientific DBS System has not been established.  Patients implanted with Boston Scientific DBS Systems without ImageReady™ MRI Technology should not be exposed to Magnetic Resonance Imaging (MRI). Patients implanted with the Vercise Gevia or Vercise Genus or Vercise Genus Mixed System with M8 Adapter or Vercise DBS Lead-Only System (before Stimulator is implanted) with ImageReady MRI Technology are Full Body MR Conditional only when exposed to the MRI environment under the specific conditions defined in ImageReady MRI Guidelines for Boston Scientific DBS Systems.  Boston Scientific DBS Systems are not recommended for patients who are unable to operate the system or are poor surgical candidates or who experience unsuccessful test stimulation.

Warnings: Unauthorized modification to the medical devices is prohibited.  You should not be exposed to high stimulation levels.  High level of stimulation may damage brain tissue.  Patients implanted with a Boston Scientific DBS System may be at risk for intracranial hemorrhages (bleeding in the brain) during DBS lead placement.  Strong electromagnetic fields, such as power generators, security screeners or theft detection systems, can potentially turn the stimulator off, or cause unpredictable changes in stimulation. The system should not be charged while sleeping.  If you notice new onset or worsening depression, changes in mood or behavior or impulse control, or have thoughts of suicide contact your physician or emergency services immediately.  Chemical burns may result if the Stimulator housing is ruptured or pierced.  The Boston Scientific DBS Systems may interfere with the operation of implanted stimulation devices, such as cardiac pacemakers, implanted cardioverter defibrillators, or medication delivery pumps. Patients should operate motorized vehicles or potentially dangerous machinery with caution.  It is unknown if the device may hurt an unborn baby. Your doctor may be able to provide additional information on the Boston Scientific DBS Systems.  For complete indications for use, contraindications, warnings, precautions, and side effects, see DBSandME.com or call 833-DBS-INFO or 833-327-4636.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.